Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons - Test2 - elhamkhani - TriplyDB

Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

http://www.wikidata.org/entity/Q27671836

about

Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types Interferon lambda: a new sword in cancer immunotherapy Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections Insights into cytokine-receptor interactions from cytokine engineering Interferon gamma receptor: the beginning of the journey Subversion of cytokine networks by virally encoded decoy receptors Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling A Single N-Acetylgalactosamine Residue at Threonine 106 Modifies the Dynamics and Structure of Interferon 2a around the Glycosylation Site Structural insights into a human anti-IFN antibody exerting therapeutic potential for systemic lupus erythematosus Structure of the activating IL-1 receptor signaling complex Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation.Instructive roles for cytokine-receptor binding parameters in determining signaling and functional potency Disease-promoting effects of type I interferons in viral, bacterial, and coinfections Interferons and viruses: an evolutionary arms race of molecular interactions Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1 Interferon-ε protects the female reproductive tract from viral and bacterial infection Contraction of the type I IFN locus and unusual constitutive expression of IFN-α in bats Functional Selectivity in Cytokine Signaling Revealed Through a Pathogenic EPO Mutation Membrane protein structure determination using crystallography and lipidic mesophases: recent advances and successes.Cytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes.Live cell micropatterning reveals the dynamics of signaling complexes at the plasma membrane Receptor dimer stabilization by hierarchical plasma membrane microcompartments regulates cytokine signaling.How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.Interferons and their stimulated genes in the tumor microenvironment Type I interferon mimetics bypass vaccinia virus decoy receptor virulence factor for protection of mice against lethal infection.Immunosuppressive small molecule discovered by structure-based virtual screening for inhibitors of protein-protein interactions.High-density nucleosome occupancy map of human chromosome 9p21-22 reveals chromatin organization of the type I interferon gene cluster.Type I interferons in bacterial infections: taming of myeloid cells and possible implications for autoimmunity.Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections Molecular evolution of the porcine type I interferon family: subtype-specific expression and antiviral activity.Differential activity of type I interferon subtypes for dendritic cell differentiation Type I interferons link viral infection to enhanced epithelial turnover and repair.Multifaceted activities of type I interferon are revealed by a receptor antagonist.Molecular basis for antagonistic activity of anifrolumab, an anti-interferon-α receptor 1 antibody Blockade of interferon Beta, but not interferon alpha, signaling controls persistent viral infection Evolutionary genetic dissection of human interferons.Inborn errors of anti-viral interferon immunity in humans.The molecular basis of IL-10 function: from receptor structure to the onset of signaling.Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.A fully human monoclonal antibody with novel binding epitope and excellent neutralizing activity to multiple human IFN-α subtypes: A candidate therapy for systemic lupus erythematosus.

P2860

Q21131160-4F2FD3B1-F221-4DFB-8D0D-DA4008E44588 Q21296797-BDC2FBB0-7717-46CA-B596-397F40C34797 Q26849516-9F9A53EA-F525-4369-95E5-79E7667D70E2 Q26852703-68A064F4-891A-4B14-A26B-634D0D53CB33 Q27004401-7C415884-BEC0-487D-AA5A-91BC40789744 Q27005694-5B949161-3BF8-46F6-B958-1969B09F34EE Q27310374-C29B17AF-D3A7-49D6-890A-FF743A40C400 Q27675256-4998F1E7-0770-42D6-8C65-5EDBC21D2E06 Q27677078-910A51E6-E991-44EA-89C8-C63F4C7A4A0F Q27678079-94D41FDD-EC37-45AB-B4D4-304600A2ABA9 Q27687338-FABB1266-3073-44B1-B232-31E413423B9C Q27702599-AA697DD9-12FB-409B-A850-C7C9B214E0CE Q28082841-6048E9D5-586D-4FEB-B1C0-EFDFE1232A29 Q28083788-F7212C98-FECA-4541-A634-A27A75400155 Q28509674-A5127E73-9336-4672-92A8-35E843ADD277 Q28586311-908D7397-A084-4B6E-9D98-6487DEAB1340 Q28602705-9D1AEC68-B084-4082-904D-0166E056B3B1 Q29147543-BEFE2340-A97B-4D17-8A31-510CA14E6D2B Q30155276-8DBDE64D-AA89-48ED-B86A-A949D105E5A4 Q30381154-7D22902A-536E-4574-9ACE-F48E56E3DCFE Q30597262-E009B2D2-52CA-4B0D-9824-FFBAC5C79502 Q30830679-958CA52E-E14B-41E7-8139-D9C7ADAF2512 Q33988240-A441F512-A74F-44E8-BE6D-995B327CDEAA Q33988567-AA06BDCB-725B-4B33-B8BB-8997BB85A57E Q34057742-82102D31-62FD-42C3-A6A7-BA3A60FCDF3A Q34077504-C3245E7B-CF91-4DC0-AB3B-5F1236C90AD4 Q34113973-67F702BC-CDD9-41A5-B3E0-57D2842A457A Q34164176-3908B1FB-F06D-48CD-8181-BA5E38358314 Q34293407-5C6E5370-6DA8-42C6-AC51-1881C969B978 Q34458694-3F2A20C6-9183-4464-A045-78E54A09982C Q34615006-D0B07DBC-FB4C-420C-A446-35A3C5616FB1 Q34978471-00D80CB8-73BE-454D-AA3C-041D2D064796 Q35031568-DD73845F-0B95-4820-A764-C7F722C60A41 Q35545957-924B9B3B-42C1-4366-BCA9-6DA9653BD9F7 Q35608012-B73F3141-C08D-4A11-ABFB-66A298264CC4 Q35627683-0DF08266-62B3-4FF0-BB7E-7BD9863351AF Q35759651-386889FB-2A00-45CC-9D06-4E0ED8CC648E Q35810601-63106EE1-24CB-4BDF-818A-EEED69EA1C06 Q35962565-A936CFF5-77A4-47A1-8034-9116F3AAE02C Q36214158-F8A8B714-5489-4E12-A15A-EDE3BF196BDC

P2860

Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons

http://www.wikidata.org/entity/Q27671836

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Structural Linkage between Lig ...... tivation by Type I Interferons

@ast

Structural Linkage between Lig ...... tivation by Type I Interferons

@en

Structural Linkage between Lig ...... tivation by Type I Interferons

@nl

type

label

Structural Linkage between Lig ...... tivation by Type I Interferons

@ast

Structural Linkage between Lig ...... tivation by Type I Interferons

@en

Structural Linkage between Lig ...... tivation by Type I Interferons

@nl

prefLabel

Structural Linkage between Lig ...... tivation by Type I Interferons

@ast

Structural Linkage between Lig ...... tivation by Type I Interferons

@en

Structural Linkage between Lig ...... tivation by Type I Interferons

@nl

P1433

Q27671836-2372E326-87D2-4E65-B318-76F8C5352028

P1476

Q27671836-0D525538-E111-4167-A297-A450907407DB

P2093

Q27671836-19DA307F-185D-4DCE-BCD8-BDBA6FF635A3

Q27671836-2288DF0E-5A07-4C36-9349-E5AF0DCD8D6B

Q27671836-241E9AC2-8197-43AB-994D-6DEEAD7275BB

Q27671836-37336A92-835B-49BF-9652-F83C440A3026

Q27671836-464B5308-C0AE-4843-A2D3-29E7287DCCD7

Q27671836-5034C06A-BE36-4878-A9CB-5B634EB38D7D

Q27671836-5794BD5B-06B7-45C1-8BC0-7150C6133BC4

Q27671836-6C7B538F-FC59-4C74-8317-363B71105807

Q27671836-A68FA677-212D-44C5-8989-16CCE8AB5B6D

Q27671836-AF3EE3B5-192D-4185-8321-08C16F3F11E0

P2860

Q27671836-00A04A5E-C58F-42EF-B701-8D5E5D848E74

Q27671836-07F061DA-1358-45A8-ADA3-96DC0C9BF477

Q27671836-095ADEFB-C3A3-4DDC-B19E-99D4EB5AB198

Q27671836-0E39C818-F33B-4B3F-8EDC-ADB4DF73AD72

Q27671836-10969335-9FFC-475E-A410-1354FCE3D562

Q27671836-1C05FB49-4596-40F6-8A73-A8C57674D3B2

Q27671836-1EAEA9ED-60C2-4A1D-A91F-C0B9CE7AE374

Q27671836-27B58FDD-A05F-447D-9EE5-A2304D981537

Q27671836-2A2D6E19-0454-4555-881C-12C6FB8CF91D

Q27671836-2C8FE8CA-204C-4589-94AB-1BB57A5122F1

P304

Q27671836-B6A91B89-380B-47B0-A925-466733B4F588

P31

Q27671836-248A10A9-C514-4CA6-8D43-C6B596E8831B

P3181

Q27671836-55ED9599-8261-4C35-A8C3-C81155B8E8FF

P356

Q27671836-CEA8B78B-61DC-4D85-BD3C-4718545796B3

P407

Q27671836-C69DEB25-8FF7-441F-A0C8-E210DB127E93

P433

Q27671836-6779AE63-4833-42A1-8618-EF6A9DE1F18A

P478

Q27671836-83F32568-B94A-4C65-ACDB-07215BAAC1C7

P50

Q27671836-CF5E5DF3-C5DA-4A2F-98CD-92AE9543BCD4

P577

Q27671836-A1C2DE73-9B10-4B7C-8157-B1183C6A9C7E

P5875

Q27671836-6EAFE5E0-9091-41F9-8C9E-2599226CBD81

P698

Q27671836-AB429893-A091-4167-88A4-47479B2F2DB5

P932

Q27671836-B34D474D-40E1-44CB-825B-9AC19345DE8B

P3181

P356

J.CELL.2011.06.048

P1433

P1476

Structural linkage between lig ...... tivation by type I interferons

@en

P2093

Angelica Trejo

http://www.w3.org/2001/XMLSchema#string

Choongho Lee

http://www.w3.org/2001/XMLSchema#string

Doron Levin

http://www.w3.org/2001/XMLSchema#string

Ganit Yarden

http://www.w3.org/2001/XMLSchema#string

Garry P Nolan

http://www.w3.org/2001/XMLSchema#string

Gideon Schreiber

http://www.w3.org/2001/XMLSchema#string

Ignacio Moraga

http://www.w3.org/2001/XMLSchema#string

Jacob Piehler

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Glenn

http://www.w3.org/2001/XMLSchema#string

K Christopher Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Structure of IL-22 bound to its high-affinity IL-22R1 chain

BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies

Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site

The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding

Crystal structure of the IL-22/IL-22R1 complex and its implications for the IL-22 signaling mechanism

Insights into MHC Class I Peptide Loading from the Structure of the Tapasin-ERp57 Thiol Oxidoreductase Heterodimer

Intermolecular Interactions in a 44 kDa Interferon−Receptor Complex Detected by Asymmetric Reverse-Protonation and Two-Dimensional NOESY

Crystal Structure of Human Interferon-λ1 in Complex with Its High-Affinity Receptor Interferon-λR1

Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography

P304

621-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4011693

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CELL.2011.06.048

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

146

http://www.w3.org/2001/XMLSchema#string

P50

Christoph Thomas

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51584038

http://www.w3.org/2001/XMLSchema#string

P698

21854986

http://www.w3.org/2001/XMLSchema#string

P932

3166218

http://www.w3.org/2001/XMLSchema#string